TIAA CREF Investment Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-29,803
Closed -$259K 3137
2018
Q1
$259K Buy
29,803
+867
+3% +$7.54K ﹤0.01% 2934
2017
Q4
$362K Sell
28,936
-3,027
-9% -$37.9K ﹤0.01% 2896
2017
Q3
$267K Buy
31,963
+1,588
+5% +$13.3K ﹤0.01% 3013
2017
Q2
$515K Buy
+30,375
New +$515K ﹤0.01% 2859
2016
Q2
Sell
-7,863
Closed -$74K 3204
2016
Q1
$74K Hold
7,863
﹤0.01% 3045
2015
Q4
$79K Buy
+7,863
New +$79K ﹤0.01% 3118